Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Duensing

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|June 1, 1997
Safety, feasibility and therapeutic activity of intrapleural autologous lymphocyte conditioned medium followed by systemic recombinant interleukin-2 and interferon-alpha in a patient with malignant pleural mesotheliomaS Duensing, H Hamm, A Ganser, et al.
Cancer Research|April 6, 2001
Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotypeS Duensing, A Duensing, C P Crum, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 14, 2000
Elevated plasma levels of interleukin-1 receptor antagonist are associated with decreased cellular BCL-2 oncoprotein expression in B-chronic lymphocytic leukemiaS Duensing, A Nasarek, J Grosse, et al.
Leukemia|November 1, 1992
Acute lymphoblastic leukemia: present and futureS C Gulati, L Acaba, P Maslak, et al.
Cancer Biotherapy|January 1, 1995
In vivo distribution of integrins in renal cell carcinoma: integrin-phenotype alteration in different degrees of tumor differentiation and VLA-2 involvement in tumor metastasisG Anastassiou, S Duensing, G Steinhoff, et al.
Oncogene|December 7, 2005
Cyclin-dependent kinase 2 is dispensable for normal centrosome duplication but required for oncogene-induced centrosome overduplicationA Duensing, Y Liu, M Tseng, et al.
Der Urologe. Ausg. A|May 23, 2013
[Management of prostate cancer in the elderly]G Hatiboglu, B Hadaschik, D Teber, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 10, 2002
Interleukin-12 inhibits apoptosis in chronic lymphatic leukemia (CLL) B cellsS Schuhknecht, S Duensing, I Dallmann, et al.
Journal of Cellular Biochemistry|September 27, 2001
Participation of Survivin in mitotic and apoptotic activities of normal and tumor-derived cellsX Jiang, C Wilford, S Duensing, et al.
Journal of Virology|July 20, 2001
Centrosome abnormalities and genomic instability by episomal expression of human papillomavirus type 16 in raft cultures of human keratinocytesS Duensing, A Duensing, E R Flores, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Cancer Biotherapy & Radiopharmaceuticals|June 1, 1997
Safety, feasibility and therapeutic activity of intrapleural autologous lymphocyte conditioned medium followed by systemic recombinant interleukin-2 and interferon-alpha in a patient with malignant pleural mesotheliomaS Duensing, H Hamm, A Ganser, et al.
Cancer Research|April 6, 2001
Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotypeS Duensing, A Duensing, C P Crum, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 14, 2000
Elevated plasma levels of interleukin-1 receptor antagonist are associated with decreased cellular BCL-2 oncoprotein expression in B-chronic lymphocytic leukemiaS Duensing, A Nasarek, J Grosse, et al.
Leukemia|November 1, 1992
Acute lymphoblastic leukemia: present and futureS C Gulati, L Acaba, P Maslak, et al.
Cancer Biotherapy|January 1, 1995
In vivo distribution of integrins in renal cell carcinoma: integrin-phenotype alteration in different degrees of tumor differentiation and VLA-2 involvement in tumor metastasisG Anastassiou, S Duensing, G Steinhoff, et al.
Oncogene|December 7, 2005
Cyclin-dependent kinase 2 is dispensable for normal centrosome duplication but required for oncogene-induced centrosome overduplicationA Duensing, Y Liu, M Tseng, et al.
Der Urologe. Ausg. A|May 23, 2013
[Management of prostate cancer in the elderly]G Hatiboglu, B Hadaschik, D Teber, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 10, 2002
Interleukin-12 inhibits apoptosis in chronic lymphatic leukemia (CLL) B cellsS Schuhknecht, S Duensing, I Dallmann, et al.
Journal of Cellular Biochemistry|September 27, 2001
Participation of Survivin in mitotic and apoptotic activities of normal and tumor-derived cellsX Jiang, C Wilford, S Duensing, et al.
Journal of Virology|July 20, 2001
Centrosome abnormalities and genomic instability by episomal expression of human papillomavirus type 16 in raft cultures of human keratinocytesS Duensing, A Duensing, E R Flores, et al.
Pageof 8